Uncovering molecular abnormalities leading to the Warburg effect in primary refractory diffuse large B-cell lymphoma

por Soleja, M, Mims, M, Rivero, G
Publicado 2016

P1102: A PHASE 1 STUDY OF PARSACLISIB IN COMBINATION WITH RITUXIMAB, BENDAMUSTINE + RITUXIMAB, OR IBRUTINIB IN PATIENTS WITH PREVIOUSLY TREATED B-CELL LYMPHOMA (CITADEL-112): PRELI...

por Sancho, J.-M., Lopez-Guillermo, A., Abrisqueta, P., Kumar, A., Cordoba, R., Tani, M., Zhao, W., Rappold, E., Langmuir, P., Mims, M.
Publicado 2022